Immune checkpoint inhibitors: Unravelling atherosclerotic cardiovascular risk.
(2025)
Journal Article
Gray, R., Manisty, C., Cheng, R., Dastidar, A., Mamas, M., & Ghosh, A. (in press). Immune checkpoint inhibitors: Unravelling atherosclerotic cardiovascular risk. Atherosclerosis, 403, Article 119147. https://doi.org/10.1016/j.atherosclerosis.2025.119147
1. Introduction
The development of immune checkpoint inhibitors (ICI) has transformed the landscape of cancer treatment in the past decade with these agents becoming the standard of care in the treatment of many malignancies [1]. There are currently...
Read More about Immune checkpoint inhibitors: Unravelling atherosclerotic cardiovascular risk..